Dafna Capital Management LLC Autolus Therapeutics PLC Transaction History

Dafna Capital Management LLC

$389 Million
Q3 2024

A detailed history of Dafna Capital Management LLC transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Dafna Capital Management LLC holds 486,667 shares of AUTL stock, worth $1.46 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

486,667

Previous 346,667 40.38%

Holding current value

$1.46 Million

Previous $1.21 Million 46.43%

% of portfolio

0.45%

Previous 0.31%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.38 - $4.69 $473,200 - $656,600	140,000 Added 40.38%	486,667 $1.77 Million
Q2 2024 Aug 14, 2024	BUY	$3.33 - $5.68 $432,900 - $738,400	130,000 Added 60.0%	346,667 $1.21 Million
Q1 2024 May 15, 2024	BUY	$5.39 - $7.29 $137,967 - $186,602	25,597 Added 13.4%	216,667 $1.38 Million
Q4 2023 Feb 14, 2024	SELL	$2.13 - $6.63 $1.57 Million - $4.89 Million	-737,183 Reduced 79.42%	191,070 $1.23 Million
Q3 2023 Nov 14, 2023	SELL	$2.32 - $3.36 $4,967 - $7,193	-2,141 Reduced 0.23%	928,253 $2.16 Million
Q2 2023 Aug 14, 2023	SELL	$1.64 - $3.21 $403,039 - $788,876	-245,756 Reduced 20.89%	930,394 $2.21 Million
Q4 2022 Feb 14, 2023	BUY	$1.74 - $3.27 $1.18 Million - $2.22 Million	680,000 Added 137.06%	1,176,150 $2.23 Million
Q1 2022 May 16, 2022	BUY	$3.52 - $5.46 $1.75 Million - $2.71 Million	496,150 New	496,150 $2.07 Million
Q3 2020 Nov 16, 2020	SELL	$11.64 - $16.3 $747,695 - $1.05 Million	-64,235 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$5.38 - $16.14 $836,939 - $2.51 Million	-155,565 Reduced 70.78%	64,235 $1.03 Million
Q1 2020 May 15, 2020	BUY	$4.2 - $13.0 $503,160 - $1.56 Million	119,800 Added 119.8%	219,800 $1.32 Million
Q2 2019 Aug 14, 2019	BUY	$15.1 - $31.25 $1.51 Million - $3.13 Million	100,000 New	100,000 $1.61 Million

Others Institutions Holding AUTL

# of Institutions

104

Shares Held

163M

Call Options Held

2.8K

Put Options Held

13.4K

View Full List

About Autolus Therapeutics plc

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $272M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

More about AUTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Account

Dafna Capital Management LLC Autolus Therapeutics PLC Transaction History